Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Public ClinicalTrials.gov record NCT00160147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.
Study identification
- NCT ID
- NCT00160147
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 60 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2005 (Type not available)
- Primary completion
- Jan 2008 (Actual)
- Completion
- Jan 2008 (Actual)
- Last update posted
- Feb 9, 2015
2005 – 2008
United States locations
- U.S. sites
- 35
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 912 | Phoenix | Arizona | — | — |
| Site 902 | Carson | California | — | — |
| Site 903 | Long Beach | California | — | — |
| Site 911 | Pasadena | California | — | — |
| Site 922 | San Marino | California | — | — |
| Site 910 | Santa Ana | California | — | — |
| Site 929 | Hamden | Connecticut | — | — |
| Site 914 | New Britain | Connecticut | — | — |
| Site 931 | Norwalk | Connecticut | — | — |
| Site 901 | Miami | Florida | — | — |
| Site 907 | North Miami | Florida | — | — |
| Site 933 | Orange City | Florida | — | — |
| Site 934 | Atlanta | Georgia | — | — |
| Site 917 | Blue Ridge | Georgia | — | — |
| Site 925 | Newnan | Georgia | — | — |
| Site 904 | New Orleans | Louisiana | — | — |
| Site 905 | Shreveport | Louisiana | — | — |
| Site 906 | Shreveport | Louisiana | — | — |
| Site 919 | Bedford | Massachusetts | — | — |
| Site 923 | Boston | Massachusetts | — | — |
| Site 942 | Flowood | Mississippi | — | — |
| Site 927 | St Louis | Missouri | — | — |
| Site 930 | St Louis | Missouri | — | — |
| Site 940 | St Louis | Missouri | — | — |
| Site 941 | Olean | New York | — | — |
| Site 921 | Staten Island | New York | — | — |
| Site 909 | Cincinnati | Ohio | — | — |
| Site 908 | Oklahoma City | Oklahoma | — | — |
| Site 916 | Oklahoma City | Oklahoma | — | — |
| Site 935 | Philadelphia | Pennsylvania | — | — |
| Site 932 | Humboldt | Tennessee | — | — |
| Site 936 | Austin | Texas | — | — |
| Site 928 | Dallas | Texas | — | — |
| Site 913 | Williamsburg | Virginia | — | — |
| Site 918 | Waukesha | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00160147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2015 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00160147 live on ClinicalTrials.gov.